{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"semax-ppis","title":"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture","body":"## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it can alter nutrient absorption, including vitamin B12 and magnesium. Observational data link extended PPI exposure to possible cognitive performance shifts in some groups, though results conflict across studies. Gut environment changes may also occur. These layers do not match classic tissue breakdown like disc height loss. They point to downstream effects on energy metabolism and neural maintenance that could outpace repair in certain users.\n\n## Why Semax might help you\n\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\n2. **What keeps failing:** BDNF decline, possible neuro stress from nutrient shifts or sustained acid suppression effects, cognitive fatigue after long-term medication load.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\nSemax is an ACTH(4-10) analog examined mainly for its effects on brain-derived neurotrophic factor pathways. If long-term PPI use contributes to B12 shortfalls or other factors that touch cognitive function, the peptide's studied upregulation of BDNF expression offers a repair-focused angle rather than further suppression.\n\n## Why PPIs (omeprazole, etc.) matters for you\n\n**Drug:** PPIs (omeprazole, etc.)\n**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\n**Therefore for you:** This drug reduces mechanical and chemical load on the esophagus and stomach lining. That can protect against ongoing irritation. At the same time it may trade off repair support by limiting acid-dependent absorption of key nutrients that feed neural and metabolic pathways. The net effect depends on duration and individual nutrient status.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Semax** → neural / cognitive\n\nSemax addresses the neural maintenance layer that observational PPI data sometimes flag. The drug itself handles the primary acid load reduction. Together they separate symptom or load control from targeted repair signaling. No overlap in mechanism is claimed.\n\n## What the evidence actually shows\n\nHuman data on Semax come mainly from post-stroke settings. One study of 110 patients after ischemic stroke found that two courses of Semax (6000 mcg/day for 10 days with a 20-day interval) increased plasma BDNF levels regardless of rehabilitation timing. Motor performance and Barthel index scores improved in the Semax groups (Gusev et al., 2018). This was a clinical trial, not a PPI-specific trial.\n\nAnimal work in rats shows Semax enhances Bdnf mRNA expression in cortex after ischemia and modulates hippocampal BDNF/trkB systems (Dolotov et al., 2006; Dmitrieva et al., 2009). These are preclinical findings.\n\nPPI and cognition links rest on observational cohorts. One analysis of over 5,700 older adults associated more than 4.4 cumulative years of PPI use with 33% higher incident dementia risk (Neurology, 2023). Other studies, including one in women and one in adults 65+, found no convincing association with cognitive decline. A Rhineland Study cross-section noted poorer global cognition and working memory in younger long-term users alongside higher mean diffusivity in white matter regions (Nature Scientific Reports, 2024). No randomized trials prove causation.\n\nNo published human trials directly examine Semax alongside PPIs.\n\n## What scientists say\n\nResearchers note Semax increases BDNF in stroke patients and supports neuronal survival under hypoxia in lab models. They emphasize the need for more data outside acute brain injury. On PPIs, gastroenterology reviews highlight acid suppression benefits while flagging nutrient monitoring for long-term users. Cognitive associations remain correlational with calls for controlled studies.\n\n## What people say on Reddit\n\nDirect discussion of Semax with PPI use is sparse in public threads. Some users mention peptides for focus or recovery while on acid reducers, but reports stay anecdotal and unverified. No consistent pattern emerges linking the two.\n\n## What people say on X\n\nSearches turn up occasional mentions of Semax for cognitive support or post-stroke recovery. PPI-related posts focus on side-effect management or deprescribing. Overlap between the topics is minimal and anecdotal.\n\n## What we do not know\n\nNo data exist on whether Semax alters PPI effects or compensates for any nutrient or cognitive associations. Human trials of Semax outside stroke or ischemia remain limited. Long-term safety of combined use is unstudied. Individual responses to either agent vary widely.\n\n## Safety and limits\n\nSemax research reports good tolerability in the studied stroke cohorts. PPIs carry established risks with prolonged use, including nutrient shortfalls and infection susceptibility. Anyone considering peptides or medication changes should consult a clinician. This article summarizes published observations only and offers no guidance on use.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-ppis/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Semax increased plasma BDNF levels in 110 post-stroke patients regardless of rehabilitation timing.","section":"What the evidence actually shows","tier":"human","source_ids":["s10"],"source_status":"sourced","why_material":"Provides the main human trial data for Semax BDNF effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax enhances Bdnf mRNA expression after ischemia and modulates hippocampal BDNF/trkB.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s9"],"source_status":"sourced","why_material":"Documents animal evidence base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Observational data link >4.4 years PPI use to 33% higher dementia risk in one cohort of 5,712 older adults.","section":"What the evidence actually shows","tier":"human","source_ids":["s20"],"source_status":"sourced","why_material":"Key human observational finding on PPIs and cognition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No direct human trials examine Semax with PPIs.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period.","summary":"110-patient stroke trial showing Semax raised BDNF.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"2629c980f3b0cfd1b6918c4936b7fa339cdca5ef9492116baeacedfa227e754b"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of ...","quote":"Semax treatment enhanced the expression of Bdnf mRNA in the cortex of ischemic rats","summary":"Rat ischemia model BDNF data.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"ok","quote_status":"unverified","prev":"2629c980f3b0cfd1b6918c4936b7fa339cdca5ef9492116baeacedfa227e754b","hash":"d205ff5b435ac8f3e6da72f132cae67eabe2f7180b09b14f4e40d5239a39cb6a"},{"id":"s20","type":"news","url":"https://gastro.org/news/study-links-long-term-ppi-use-with-dementia/","title":"Another study links PPIs and dementia","quote":"long term PPI use, defined as more than 4.5 years of use, was associated with dementia","summary":"Reports the Neurology 2023 PPI dementia association.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"http_503","quote_status":"unverified","prev":"d205ff5b435ac8f3e6da72f132cae67eabe2f7180b09b14f4e40d5239a39cb6a","hash":"56ef77ef1bf32d7d51f30073d6cc972436c70347f5501b48d5c679e0ee91df30"},{"id":"s21","type":"pubmed","url":"https://www.nature.com/articles/s41598-024-81011-y","title":"The impact of proton pump inhibitors on brain health based on ...","quote":"PPI users, especially younger individuals, showed poorer global cognition and working memory.","summary":"Rhineland Study on PPI cognition links.","claim_ids":[],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"ok","quote_status":"verified","prev":"56ef77ef1bf32d7d51f30073d6cc972436c70347f5501b48d5c679e0ee91df30","hash":"8f7a3f9ea90f6090de8254f488817f361c213bc326f14363898c2443c639f602"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:04:54.371Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture","register":"source_ledger","body":"## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it can alter nutrient absorption, including vitamin B12 and magnesium. Observational data link extended PPI exposure to possible cognitive performance shifts in some groups, though results conflict across studies. Gut environment changes may also occur. These layers do not match classic tissue breakdown like disc height loss. They point to downstream effects on energy metabolism and neural maintenance that could outpace repair in certain users.\n\n## Why Semax might help you\n\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\n2. **What keeps failing:** BDNF decline, possible neuro stress from nutrient shifts or sustained acid suppression effects, cognitive fatigue after long-term medication load.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\nSemax is an ACTH(4-10) analog examined mainly for its effects on brain-derived neurotrophic factor pathways. If long-term PPI use contributes to B12 shortfalls or other factors that touch cognitive function, the peptide's studied upregulation of BDNF expression offers a repair-focused angle rather than further suppression.\n\n## Why PPIs (omeprazole, etc.) matters for you\n\n**Drug:** PPIs (omeprazole, etc.)\n**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\n**Therefore for you:** This drug reduces mechanical and chemical load on the esophagus and stomach lining. That can protect against ongoing irritation. At the same time it may trade off repair support by limiting acid-dependent absorption of key nutrients that feed neural and metabolic pathways. The net effect depends on duration and individual nutrient status.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Semax** → neural / cognitive\n\nSemax addresses the neural maintenance layer that observational PPI data sometimes flag. The drug itself handles the primary acid load reduction. Together they separate symptom or load control from targeted repair signaling. No overlap in mechanism is claimed.\n\n## What the evidence actually shows\n\nHuman data on Semax come mainly from post-stroke settings. One study of 110 patients after ischemic stroke found that two courses of Semax (6000 mcg/day for 10 days with a 20-day interval) increased plasma BDNF levels regardless of rehabilitation timing. Motor performance and Barthel index scores improved in the Semax groups (Gusev et al., 2018). This was a clinical trial, not a PPI-specific trial.\n\nAnimal work in rats shows Semax enhances Bdnf mRNA expression in cortex after ischemia and modulates hippocampal BDNF/trkB systems (Dolotov et al., 2006; Dmitrieva et al., 2009). These are preclinical findings.\n\nPPI and cognition links rest on observational cohorts. One analysis of over 5,700 older adults associated more than 4.4 cumulative years of PPI use with 33% higher incident dementia risk (Neurology, 2023). Other studies, including one in women and one in adults 65+, found no convincing association with cognitive decline. A Rhineland Study cross-section noted poorer global cognition and working memory in younger long-term users alongside higher mean diffusivity in white matter regions (Nature Scientific Reports, 2024). No randomized trials prove causation.\n\nNo published human trials directly examine Semax alongside PPIs.\n\n## What scientists say\n\nResearchers note Semax increases BDNF in stroke patients and supports neuronal survival under hypoxia in lab models. They emphasize the need for more data outside acute brain injury. On PPIs, gastroenterology reviews highlight acid suppression benefits while flagging nutrient monitoring for long-term users. Cognitive associations remain correlational with calls for controlled studies.\n\n## What people say on Reddit\n\nDirect discussion of Semax with PPI use is sparse in public threads. Some users mention peptides for focus or recovery while on acid reducers, but reports stay anecdotal and unverified. No consistent pattern emerges linking the two.\n\n## What people say on X\n\nSearches turn up occasional mentions of Semax for cognitive support or post-stroke recovery. PPI-related posts focus on side-effect management or deprescribing. Overlap between the topics is minimal and anecdotal.\n\n## What we do not know\n\nNo data exist on whether Semax alters PPI effects or compensates for any nutrient or cognitive associations. Human trials of Semax outside stroke or ischemia remain limited. Long-term safety of combined use is unstudied. Individual responses to either agent vary widely.\n\n## Safety and limits\n\nSemax research reports good tolerability in the studied stroke cohorts. PPIs carry established risks with prolonged use, including nutrient shortfalls and infection susceptibility. Anyone considering peptides or medication changes should consult a clinician. This article summarizes published observations only and offers no guidance on use.","claims":[{"id":"c1","text":"Semax increased plasma BDNF levels in 110 post-stroke patients regardless of rehabilitation timing.","section":"What the evidence actually shows","tier":"human","source_ids":["s10"],"source_status":"sourced","why_material":"Provides the main human trial data for Semax BDNF effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax enhances Bdnf mRNA expression after ischemia and modulates hippocampal BDNF/trkB.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s9"],"source_status":"sourced","why_material":"Documents animal evidence base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Observational data link >4.4 years PPI use to 33% higher dementia risk in one cohort of 5,712 older adults.","section":"What the evidence actually shows","tier":"human","source_ids":["s20"],"source_status":"sourced","why_material":"Key human observational finding on PPIs and cognition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No direct human trials examine Semax with PPIs.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period.","link_status":"ok","quote_status":"verified"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of ...","quote":"Semax treatment enhanced the expression of Bdnf mRNA in the cortex of ischemic rats","link_status":"ok","quote_status":"unverified"},{"id":"s20","type":"news","url":"https://gastro.org/news/study-links-long-term-ppi-use-with-dementia/","title":"Another study links PPIs and dementia","quote":"long term PPI use, defined as more than 4.5 years of use, was associated with dementia","link_status":"http_503","quote_status":"unverified"},{"id":"s21","type":"pubmed","url":"https://www.nature.com/articles/s41598-024-81011-y","title":"The impact of proton pump inhibitors on brain health based on ...","quote":"PPI users, especially younger individuals, showed poorer global cognition and working memory.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":14981,"tokens_out":3193,"cost":0.02670875,"prev_hash":"genesis","hash":"26605768aea46004c5a36d87715ea16f819f9f197e62618a25d8bac481ef2dbb"}],"provenance":[{"ts":"2026-06-30T00:04:54.371Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Ppis\nSlug: semax-ppis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"PPIs (omeprazole, etc.)\",\"condition_key\":\"ppis\",\"primary_peptide\":\"semax\",\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[\"ppis\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have PPIs (omeprazole, etc.)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\",\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n4. **Therefore for you:** If that layer is part of your pr","response":"{\n  \"slug\": \"semax-ppis\",\n  \"title\": \"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture\",\n  \"body\": \"## What's breaking down if you have PPIs (omeprazole, etc.)\\n\\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it can alter nutrient absorption, including vitamin B12 and magnesium. Observational data link extended PPI exposure to possible cognitive performance shifts in some groups, though results conflict across studies. Gut environment changes may also occur. These layers do not match classic tissue breakdown like disc height loss. They point to downstream effects on energy metabolism and neural maintenance that could outpace repair in certain users.\\n\\n## Why Semax might help you\\n\\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** BDNF decline, possible neuro stress from nutrient shifts or sustained acid suppression effects, cognitive fatigue after long-term medication load.\\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\\n\\nSemax is an ACTH(4-10) analog examined mainly for its effects on brain-derived neurotrophic factor pathways. If long-term PPI use contributes to B12 shortfalls or other factors that touch cognitive function, the peptide's studied upregulation of BDNF expression offers a repair-focused angle rather than further suppression.\\n\\n## Why PPIs (omeprazole, etc.) matters for you\\n\\n**Drug:** PPIs (omeprazole, etc.)\\n**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\\n**Therefore for you:** This drug reduces mechanical and chemical load on the esophag","tokens_in":14981,"tokens_out":3193,"cost":0,"prev":"genesis","hash":"466b20562aa2fb187a0b29897d0e9e678771f2a14198a5215e8d9beee15283db"},{"ts":"2026-07-17T02:41:57.123Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-ppis","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"466b20562aa2fb187a0b29897d0e9e678771f2a14198a5215e8d9beee15283db","hash":"4a3b20fee9b2b7751f4826e511566f8eda8edd4c6b3ce0e1f2910319c9fb4200"}],"energy":{"passes":2,"tokens_in":14981,"tokens_out":3193,"tokens_total":18174,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"4a3b20fee9b2b7751f4826e511566f8eda8edd4c6b3ce0e1f2910319c9fb4200"},"posted_at":"2026-06-29T21:33:18.833Z","created_at":"2026-06-29T21:33:18.833Z","updated_at":"2026-07-17T02:41:57.123Z","machine":{"shape":"article.machine/v1","slug":"semax-ppis","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-ppis","json":"https://miscsubjects.com/api/articles/semax-ppis","bundle":"https://miscsubjects.com/api/articles/semax-ppis/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-ppis/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-ppis","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-ppis\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-ppis\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-ppis/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-ppis\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-ppis | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-ppis","json":"/api/articles/semax-ppis","markdown":"/api/articles/semax-ppis/bundle?format=markdown","skill":"/api/articles/semax-ppis/skill","topology":"/api/articles/semax-ppis/topology","versions":"/api/articles/semax-ppis/revisions","invocations":"/api/articles/semax-ppis/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-ppis","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"17e065fe7b6148719498ad510f548ff6fc5187ba127daf1c1b2e30cfad61c669","object":{"object_type":"article-object","identity":{"id":"article:semax-ppis","slug":"semax-ppis","title":"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/semax-ppis","role":"explain","audience":"human"},"skill":{"route":"/api/articles/semax-ppis/skill","role":"direct behavior","audience":"model","content":"---\nname: semax-ppis\ndescription: Apply the Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture\n\nThis Skill is the behavioral expression of [the canonical article](/a/semax-ppis). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/semax-ppis.\n- Read claims and relationships at /api/articles/semax-ppis/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have PPIs omeprazole, etc. Long-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it c\n\n## Representations\n\n- Human: /a/semax-ppis\n- JSON: /api/articles/semax-ppis\n- Relationships: /api/articles/semax-ppis/topology\n- History: /api/articles/semax-ppis/revisions\n"},"json":{"route":"/api/articles/semax-ppis","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/semax-ppis/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","semax","ppis"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/semax-ppis/invocations?status=success","failure_events":"/api/articles/semax-ppis/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"semax-ppis","title":"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture","body":"## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it can alter nutrient absorption, including vitamin B12 and magnesium. Observational data link extended PPI exposure to possible cognitive performance shifts in some groups, though results conflict across studies. Gut environment changes may also occur. These layers do not match classic tissue breakdown like disc height loss. They point to downstream effects on energy metabolism and neural maintenance that could outpace repair in certain users.\n\n## Why Semax might help you\n\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\n2. **What keeps failing:** BDNF decline, possible neuro stress from nutrient shifts or sustained acid suppression effects, cognitive fatigue after long-term medication load.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\nSemax is an ACTH(4-10) analog examined mainly for its effects on brain-derived neurotrophic factor pathways. If long-term PPI use contributes to B12 shortfalls or other factors that touch cognitive function, the peptide's studied upregulation of BDNF expression offers a repair-focused angle rather than further suppression.\n\n## Why PPIs (omeprazole, etc.) matters for you\n\n**Drug:** PPIs (omeprazole, etc.)\n**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\n**Therefore for you:** This drug reduces mechanical and chemical load on the esophagus and stomach lining. That can protect against ongoing irritation. At the same time it may trade off repair support by limiting acid-dependent absorption of key nutrients that feed neural and metabolic pathways. The net effect depends on duration and individual nutrient status.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Semax** → neural / cognitive\n\nSemax addresses the neural maintenance layer that observational PPI data sometimes flag. The drug itself handles the primary acid load reduction. Together they separate symptom or load control from targeted repair signaling. No overlap in mechanism is claimed.\n\n## What the evidence actually shows\n\nHuman data on Semax come mainly from post-stroke settings. One study of 110 patients after ischemic stroke found that two courses of Semax (6000 mcg/day for 10 days with a 20-day interval) increased plasma BDNF levels regardless of rehabilitation timing. Motor performance and Barthel index scores improved in the Semax groups (Gusev et al., 2018). This was a clinical trial, not a PPI-specific trial.\n\nAnimal work in rats shows Semax enhances Bdnf mRNA expression in cortex after ischemia and modulates hippocampal BDNF/trkB systems (Dolotov et al., 2006; Dmitrieva et al., 2009). These are preclinical findings.\n\nPPI and cognition links rest on observational cohorts. One analysis of over 5,700 older adults associated more than 4.4 cumulative years of PPI use with 33% higher incident dementia risk (Neurology, 2023). Other studies, including one in women and one in adults 65+, found no convincing association with cognitive decline. A Rhineland Study cross-section noted poorer global cognition and working memory in younger long-term users alongside higher mean diffusivity in white matter regions (Nature Scientific Reports, 2024). No randomized trials prove causation.\n\nNo published human trials directly examine Semax alongside PPIs.\n\n## What scientists say\n\nResearchers note Semax increases BDNF in stroke patients and supports neuronal survival under hypoxia in lab models. They emphasize the need for more data outside acute brain injury. On PPIs, gastroenterology reviews highlight acid suppression benefits while flagging nutrient monitoring for long-term users. Cognitive associations remain correlational with calls for controlled studies.\n\n## What people say on Reddit\n\nDirect discussion of Semax with PPI use is sparse in public threads. Some users mention peptides for focus or recovery while on acid reducers, but reports stay anecdotal and unverified. No consistent pattern emerges linking the two.\n\n## What people say on X\n\nSearches turn up occasional mentions of Semax for cognitive support or post-stroke recovery. PPI-related posts focus on side-effect management or deprescribing. Overlap between the topics is minimal and anecdotal.\n\n## What we do not know\n\nNo data exist on whether Semax alters PPI effects or compensates for any nutrient or cognitive associations. Human trials of Semax outside stroke or ischemia remain limited. Long-term safety of combined use is unstudied. Individual responses to either agent vary widely.\n\n## Safety and limits\n\nSemax research reports good tolerability in the studied stroke cohorts. PPIs carry established risks with prolonged use, including nutrient shortfalls and infection susceptibility. Anyone considering peptides or medication changes should consult a clinician. This article summarizes published observations only and offers no guidance on use.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-ppis/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Semax increased plasma BDNF levels in 110 post-stroke patients regardless of rehabilitation timing.","section":"What the evidence actually shows","tier":"human","source_ids":["s10"],"source_status":"sourced","why_material":"Provides the main human trial data for Semax BDNF effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax enhances Bdnf mRNA expression after ischemia and modulates hippocampal BDNF/trkB.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s9"],"source_status":"sourced","why_material":"Documents animal evidence base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Observational data link >4.4 years PPI use to 33% higher dementia risk in one cohort of 5,712 older adults.","section":"What the evidence actually shows","tier":"human","source_ids":["s20"],"source_status":"sourced","why_material":"Key human observational finding on PPIs and cognition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No direct human trials examine Semax with PPIs.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period.","summary":"110-patient stroke trial showing Semax raised BDNF.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"2629c980f3b0cfd1b6918c4936b7fa339cdca5ef9492116baeacedfa227e754b"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of ...","quote":"Semax treatment enhanced the expression of Bdnf mRNA in the cortex of ischemic rats","summary":"Rat ischemia model BDNF data.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"ok","quote_status":"unverified","prev":"2629c980f3b0cfd1b6918c4936b7fa339cdca5ef9492116baeacedfa227e754b","hash":"d205ff5b435ac8f3e6da72f132cae67eabe2f7180b09b14f4e40d5239a39cb6a"},{"id":"s20","type":"news","url":"https://gastro.org/news/study-links-long-term-ppi-use-with-dementia/","title":"Another study links PPIs and dementia","quote":"long term PPI use, defined as more than 4.5 years of use, was associated with dementia","summary":"Reports the Neurology 2023 PPI dementia association.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"http_503","quote_status":"unverified","prev":"d205ff5b435ac8f3e6da72f132cae67eabe2f7180b09b14f4e40d5239a39cb6a","hash":"56ef77ef1bf32d7d51f30073d6cc972436c70347f5501b48d5c679e0ee91df30"},{"id":"s21","type":"pubmed","url":"https://www.nature.com/articles/s41598-024-81011-y","title":"The impact of proton pump inhibitors on brain health based on ...","quote":"PPI users, especially younger individuals, showed poorer global cognition and working memory.","summary":"Rhineland Study on PPI cognition links.","claim_ids":[],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.471Z","link_status":"ok","quote_status":"verified","prev":"56ef77ef1bf32d7d51f30073d6cc972436c70347f5501b48d5c679e0ee91df30","hash":"8f7a3f9ea90f6090de8254f488817f361c213bc326f14363898c2443c639f602"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:04:54.371Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture","register":"source_ledger","body":"## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it can alter nutrient absorption, including vitamin B12 and magnesium. Observational data link extended PPI exposure to possible cognitive performance shifts in some groups, though results conflict across studies. Gut environment changes may also occur. These layers do not match classic tissue breakdown like disc height loss. They point to downstream effects on energy metabolism and neural maintenance that could outpace repair in certain users.\n\n## Why Semax might help you\n\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\n2. **What keeps failing:** BDNF decline, possible neuro stress from nutrient shifts or sustained acid suppression effects, cognitive fatigue after long-term medication load.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\nSemax is an ACTH(4-10) analog examined mainly for its effects on brain-derived neurotrophic factor pathways. If long-term PPI use contributes to B12 shortfalls or other factors that touch cognitive function, the peptide's studied upregulation of BDNF expression offers a repair-focused angle rather than further suppression.\n\n## Why PPIs (omeprazole, etc.) matters for you\n\n**Drug:** PPIs (omeprazole, etc.)\n**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\n**Therefore for you:** This drug reduces mechanical and chemical load on the esophagus and stomach lining. That can protect against ongoing irritation. At the same time it may trade off repair support by limiting acid-dependent absorption of key nutrients that feed neural and metabolic pathways. The net effect depends on duration and individual nutrient status.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Semax** → neural / cognitive\n\nSemax addresses the neural maintenance layer that observational PPI data sometimes flag. The drug itself handles the primary acid load reduction. Together they separate symptom or load control from targeted repair signaling. No overlap in mechanism is claimed.\n\n## What the evidence actually shows\n\nHuman data on Semax come mainly from post-stroke settings. One study of 110 patients after ischemic stroke found that two courses of Semax (6000 mcg/day for 10 days with a 20-day interval) increased plasma BDNF levels regardless of rehabilitation timing. Motor performance and Barthel index scores improved in the Semax groups (Gusev et al., 2018). This was a clinical trial, not a PPI-specific trial.\n\nAnimal work in rats shows Semax enhances Bdnf mRNA expression in cortex after ischemia and modulates hippocampal BDNF/trkB systems (Dolotov et al., 2006; Dmitrieva et al., 2009). These are preclinical findings.\n\nPPI and cognition links rest on observational cohorts. One analysis of over 5,700 older adults associated more than 4.4 cumulative years of PPI use with 33% higher incident dementia risk (Neurology, 2023). Other studies, including one in women and one in adults 65+, found no convincing association with cognitive decline. A Rhineland Study cross-section noted poorer global cognition and working memory in younger long-term users alongside higher mean diffusivity in white matter regions (Nature Scientific Reports, 2024). No randomized trials prove causation.\n\nNo published human trials directly examine Semax alongside PPIs.\n\n## What scientists say\n\nResearchers note Semax increases BDNF in stroke patients and supports neuronal survival under hypoxia in lab models. They emphasize the need for more data outside acute brain injury. On PPIs, gastroenterology reviews highlight acid suppression benefits while flagging nutrient monitoring for long-term users. Cognitive associations remain correlational with calls for controlled studies.\n\n## What people say on Reddit\n\nDirect discussion of Semax with PPI use is sparse in public threads. Some users mention peptides for focus or recovery while on acid reducers, but reports stay anecdotal and unverified. No consistent pattern emerges linking the two.\n\n## What people say on X\n\nSearches turn up occasional mentions of Semax for cognitive support or post-stroke recovery. PPI-related posts focus on side-effect management or deprescribing. Overlap between the topics is minimal and anecdotal.\n\n## What we do not know\n\nNo data exist on whether Semax alters PPI effects or compensates for any nutrient or cognitive associations. Human trials of Semax outside stroke or ischemia remain limited. Long-term safety of combined use is unstudied. Individual responses to either agent vary widely.\n\n## Safety and limits\n\nSemax research reports good tolerability in the studied stroke cohorts. PPIs carry established risks with prolonged use, including nutrient shortfalls and infection susceptibility. Anyone considering peptides or medication changes should consult a clinician. This article summarizes published observations only and offers no guidance on use.","claims":[{"id":"c1","text":"Semax increased plasma BDNF levels in 110 post-stroke patients regardless of rehabilitation timing.","section":"What the evidence actually shows","tier":"human","source_ids":["s10"],"source_status":"sourced","why_material":"Provides the main human trial data for Semax BDNF effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax enhances Bdnf mRNA expression after ischemia and modulates hippocampal BDNF/trkB.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s9"],"source_status":"sourced","why_material":"Documents animal evidence base.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Observational data link >4.4 years PPI use to 33% higher dementia risk in one cohort of 5,712 older adults.","section":"What the evidence actually shows","tier":"human","source_ids":["s20"],"source_status":"sourced","why_material":"Key human observational finding on PPIs and cognition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No direct human trials examine Semax with PPIs.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:53.618Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period.","link_status":"ok","quote_status":"verified"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of ...","quote":"Semax treatment enhanced the expression of Bdnf mRNA in the cortex of ischemic rats","link_status":"ok","quote_status":"unverified"},{"id":"s20","type":"news","url":"https://gastro.org/news/study-links-long-term-ppi-use-with-dementia/","title":"Another study links PPIs and dementia","quote":"long term PPI use, defined as more than 4.5 years of use, was associated with dementia","link_status":"http_503","quote_status":"unverified"},{"id":"s21","type":"pubmed","url":"https://www.nature.com/articles/s41598-024-81011-y","title":"The impact of proton pump inhibitors on brain health based on ...","quote":"PPI users, especially younger individuals, showed poorer global cognition and working memory.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":14981,"tokens_out":3193,"cost":0.02670875,"prev_hash":"genesis","hash":"26605768aea46004c5a36d87715ea16f819f9f197e62618a25d8bac481ef2dbb"}],"provenance":[{"ts":"2026-06-30T00:04:54.371Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Ppis\nSlug: semax-ppis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"PPIs (omeprazole, etc.)\",\"condition_key\":\"ppis\",\"primary_peptide\":\"semax\",\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[\"ppis\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have PPIs (omeprazole, etc.)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\",\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n4. **Therefore for you:** If that layer is part of your pr","response":"{\n  \"slug\": \"semax-ppis\",\n  \"title\": \"Semax for PPIs: Neural Support Angles When Acid Suppression Is in the Picture\",\n  \"body\": \"## What's breaking down if you have PPIs (omeprazole, etc.)\\n\\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces acid-related damage to the esophagus and stomach lining in the short term. Over months or years it can alter nutrient absorption, including vitamin B12 and magnesium. Observational data link extended PPI exposure to possible cognitive performance shifts in some groups, though results conflict across studies. Gut environment changes may also occur. These layers do not match classic tissue breakdown like disc height loss. They point to downstream effects on energy metabolism and neural maintenance that could outpace repair in certain users.\\n\\n## Why Semax might help you\\n\\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** BDNF decline, possible neuro stress from nutrient shifts or sustained acid suppression effects, cognitive fatigue after long-term medication load.\\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\\n\\nSemax is an ACTH(4-10) analog examined mainly for its effects on brain-derived neurotrophic factor pathways. If long-term PPI use contributes to B12 shortfalls or other factors that touch cognitive function, the peptide's studied upregulation of BDNF expression offers a repair-focused angle rather than further suppression.\\n\\n## Why PPIs (omeprazole, etc.) matters for you\\n\\n**Drug:** PPIs (omeprazole, etc.)\\n**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\\n**Therefore for you:** This drug reduces mechanical and chemical load on the esophag","tokens_in":14981,"tokens_out":3193,"cost":0,"prev":"genesis","hash":"466b20562aa2fb187a0b29897d0e9e678771f2a14198a5215e8d9beee15283db"},{"ts":"2026-07-17T02:41:57.123Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-ppis","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"466b20562aa2fb187a0b29897d0e9e678771f2a14198a5215e8d9beee15283db","hash":"4a3b20fee9b2b7751f4826e511566f8eda8edd4c6b3ce0e1f2910319c9fb4200"}],"energy":{"passes":2,"tokens_in":14981,"tokens_out":3193,"tokens_total":18174,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"4a3b20fee9b2b7751f4826e511566f8eda8edd4c6b3ce0e1f2910319c9fb4200"},"posted_at":"2026-06-29T21:33:18.833Z","created_at":"2026-06-29T21:33:18.833Z","updated_at":"2026-07-17T02:41:57.123Z","machine":{"shape":"article.machine/v1","slug":"semax-ppis","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-ppis","json":"https://miscsubjects.com/api/articles/semax-ppis","bundle":"https://miscsubjects.com/api/articles/semax-ppis/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-ppis/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-ppis","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-ppis\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-ppis\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-ppis/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-ppis\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-ppis | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-ppis","json":"/api/articles/semax-ppis","markdown":"/api/articles/semax-ppis/bundle?format=markdown","skill":"/api/articles/semax-ppis/skill","topology":"/api/articles/semax-ppis/topology","versions":"/api/articles/semax-ppis/revisions","invocations":"/api/articles/semax-ppis/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-ppis","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"17e065fe7b6148719498ad510f548ff6fc5187ba127daf1c1b2e30cfad61c669"}}}